Author:
Chen Rui,Jiang Chaojun,Zhu Qiannan,You Sainan,Li Yan,Li Shuo,Ding Lei,Meng Haojie,Yang Yuxin,Zha Xiaoming,Wang Jue
Funder
National Outstanding Youth Foundation of China
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference18 articles.
1. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020
2. Long-term follow-up study in breast cancer patients using serum tumor markers CEA and CA 15-3;Lumachi;Anticancer Res,1999
3. Clinical significance of serum CA15-3 as a prognostic parameter during follow-up periods in patients with breast cancer;Chu;Ann Surg Treat Res,2016
4. CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients;Incoronato;BMC Cancer,2014
5. Tumor abnormal protein (TAP) examination contributes to primary diagnosis of bladder cancer;Zhang;Int J Clin Exp Med,2015
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献